A combination of molecular markers and clinical features improve the classification of pancreatic cysts. Read more about A combination of molecular markers and clinical features improve the classification of pancreatic cysts.
Mutation spectrum and risk of colorectal cancer in African American families with Lynch syndrome. Read more about Mutation spectrum and risk of colorectal cancer in African American families with Lynch syndrome.
786 Alcohol Consumption Increases the Risk of Gastrointestinal Bleeding in Men. Read more about 786 Alcohol Consumption Increases the Risk of Gastrointestinal Bleeding in Men.
783 Menopausal Hormone Therapy Is Associated With Increased Risk of Lower Gastrointestinal Bleeding. Read more about 783 Menopausal Hormone Therapy Is Associated With Increased Risk of Lower Gastrointestinal Bleeding.
Confocal laser endomicroscopy for membrane-bound tumor necrosis factor predicts response to therapy in Crohn's disease. Read more about Confocal laser endomicroscopy for membrane-bound tumor necrosis factor predicts response to therapy in Crohn's disease.
NFATc1 Links EGFR Signaling to Induction of Sox9 Transcription and Acinar-Ductal Transdifferentiation in the Pancreas. Read more about NFATc1 Links EGFR Signaling to Induction of Sox9 Transcription and Acinar-Ductal Transdifferentiation in the Pancreas.
The bile acid receptor TGR5 activates the TRPA1 channel to induce itch in mice. Read more about The bile acid receptor TGR5 activates the TRPA1 channel to induce itch in mice.
The diagnostic approach to monogenic very early onset inflammatory bowel disease. Read more about The diagnostic approach to monogenic very early onset inflammatory bowel disease.
Insights into the molecular pathophysiology of inflammatory bowel disease: ATG16L1 suppresses nod-driven inflammation. Read more about Insights into the molecular pathophysiology of inflammatory bowel disease: ATG16L1 suppresses nod-driven inflammation.
CpG island methylator phenotype is associated with response to adjuvant irinotecan-based therapy for stage III colon cancer. Read more about CpG island methylator phenotype is associated with response to adjuvant irinotecan-based therapy for stage III colon cancer.
